Heart failure is a major public health concern and one of the most frequent causes of hospitalization. An estimated 6.2 million Americans =20 years of age have heart failure; the incidence is projected to increase 46% from 2012 to 2030. Heart failure typically occurs on the left side of the heart, but cardiac dysfunction can expand and impact the right side, causing biventricular failure. Experience with pharmacological therapy or a resynchronization device has been very limited. The latter can provide symptomatic and survival benefits; however, many patients develop progressive symptoms refractory to further medical therapy, requiring some sort of mechanical circulatory support (MCS) device.
The primary aim of the current Research Topic is to propose and discuss current management strategies for biventricular failure patients with MCS devices, such as the left ventricular assist device, the biventricular assist device, and the total artificial heart. Other MCS modalities, including under-developing implantable devices, and short-term devices, such as extracorporeal membrane oxygenation and percutaneous devices can also be discussed.
Frontiers in Cardiovascular Medicine publishes peer-reviewed research articles across basic, translational, and clinical cardiovascular medicine. We invite authors to submit any article types of manuscripts accepted by Frontiers such as original research articles, reviews, mini-reviews, and case reports.
Heart failure is a major public health concern and one of the most frequent causes of hospitalization. An estimated 6.2 million Americans =20 years of age have heart failure; the incidence is projected to increase 46% from 2012 to 2030. Heart failure typically occurs on the left side of the heart, but cardiac dysfunction can expand and impact the right side, causing biventricular failure. Experience with pharmacological therapy or a resynchronization device has been very limited. The latter can provide symptomatic and survival benefits; however, many patients develop progressive symptoms refractory to further medical therapy, requiring some sort of mechanical circulatory support (MCS) device.
The primary aim of the current Research Topic is to propose and discuss current management strategies for biventricular failure patients with MCS devices, such as the left ventricular assist device, the biventricular assist device, and the total artificial heart. Other MCS modalities, including under-developing implantable devices, and short-term devices, such as extracorporeal membrane oxygenation and percutaneous devices can also be discussed.
Frontiers in Cardiovascular Medicine publishes peer-reviewed research articles across basic, translational, and clinical cardiovascular medicine. We invite authors to submit any article types of manuscripts accepted by Frontiers such as original research articles, reviews, mini-reviews, and case reports.
